Claims for Patent: 9,931,304

Summary for Patent: 9,931,304

Title:	Method of making particles for use in a pharmaceutical composition
Abstract:	The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method.
Inventor(s):	Staniforth; John Nicholas (Wiltshire, GB), Green; Matthew Michael (Wiltshire, GB), Morton; David Alexander Vodden (Wiltshire, GB)
Assignee:	VECTURA LIMITED (Chippenham, GB)
Application Number:	14/553,187
Patent Claims:	1. Composite active particles for use in a pharmaceutical composition for pulmonary administration, each composite active particle comprising a particle of active material and magnesium stearate fused on the surface of that particle of active material, the composite active particles having a mass median aerodynamic diameter of not more than 10 .mu.m, the magnesium stearate being applied to the particles of active material using a curved element applying high shear and compressive force. 2. Composite active particles as claimed in claim 1, which are in the form of agglomerated composite active particles. 3. Composite particles as claimed in claim 1 in which the additive particles form a coating on the surface of the particles of active material. 4. Composite active particles as claimed in claim 3 in which the coating is a discontinuous coating. 5. Composite active particles as claimed in claim 3 in which the coating is not more than 1 .mu.m thick. 6. Composite active particles as claimed in claim 1, wherein the active material comprises one or more of: a steroid, a cromone, a .beta.2 agonist, or a leukotriene receptor antagonist. 7. Composite active particles as claimed in claim 1, wherein the active particles comprise terbutaline, salbutamol, salmeterol, formoterol or glycopyrrolate. 8. Composite active particles as claimed in claim 1, wherein the high shear and compressive force is achieved using a gap of predetermined width. 9. Composite active particles as claimed in claim 8, wherein the gap is not more than 10 mm wide. 10. A pharmaceutical composition comprising composite active particles, each composite active particle comprising a particle of active material and magnesium stearate fused on the surface of that particle of active material, the composite active particles having a mass median aerodynamic diameter of not more than 10 .mu.m, the magnesium stearate being applied to the particles of active material using a curved element applying high shear and compressive force. 11. A pharmaceutical composition as claimed in claim 10, which is a dry powder and is suitable for use in a dry powder inhaler. 12. A pharmaceutical composition as claimed in claim 10, which comprises a propellant and is suitable for use in a pressurized metered dose inhaler. 13. A pharmaceutical composition as claimed in claim 10, wherein the high shear and compressive force is achieved using a gap of predetermined width. 14. A pharmaceutical composition as claimed in claim 13, wherein the gap is not more than 10 mm wide.